With the growth in fragment-based drug discovery, numerous strategies have been described for the design of fragment libraries. Key choices need to be made on both the selection criteria to be applied and the source of the fragments in the library. Here we review some of the key trends and recent developments in the rapidly evolving field of fragment library design, providing an overview of current design strategies and surveying the characteristics of published fragment libraries. © 2010 Published by Elsevier Ltd
The use of fragments with low binding affinity for their targets as starting points has received muc...
The first step in hit optimisation is the identification of the pharmacophore, which is normally ach...
Fragment-based drug discovery (FBDD) has grown and matured to a point where it is valuable to keep t...
As fragment-based drug design has become established as a standard component of the drug discovery a...
Fragment-based drug discovery (FBDD) is well suited for discovering both drug leads and chemical pro...
In this review, a general introduction to fragment-based drug design and the underlying concepts is ...
This book presents a company-based view of the recent progresses in fragment-based drug discovery (F...
Fragment-based strategy in drug design involves the initial discovery of low-molecular mass molecule...
Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated f...
The availability of suitable diverse fragment- and lead-oriented screening compounds is key for the ...
Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated f...
Current fragment-based drug design relies on the efficient exploration of chemical space by using st...
The challenging question of the modern pharmaceutical industry is why do fragment hits provide a new...
The use of fragments with low binding affinity for their targets as starting points has received muc...
The first step in hit optimisation is the identification of the pharmacophore, which is normally ach...
Fragment-based drug discovery (FBDD) has grown and matured to a point where it is valuable to keep t...
As fragment-based drug design has become established as a standard component of the drug discovery a...
Fragment-based drug discovery (FBDD) is well suited for discovering both drug leads and chemical pro...
In this review, a general introduction to fragment-based drug design and the underlying concepts is ...
This book presents a company-based view of the recent progresses in fragment-based drug discovery (F...
Fragment-based strategy in drug design involves the initial discovery of low-molecular mass molecule...
Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated f...
The availability of suitable diverse fragment- and lead-oriented screening compounds is key for the ...
Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated f...
Current fragment-based drug design relies on the efficient exploration of chemical space by using st...
The challenging question of the modern pharmaceutical industry is why do fragment hits provide a new...
The use of fragments with low binding affinity for their targets as starting points has received muc...
The first step in hit optimisation is the identification of the pharmacophore, which is normally ach...
Fragment-based drug discovery (FBDD) has grown and matured to a point where it is valuable to keep t...